All In Biotech

Drug Trial Radar · NCT07489651

RE104 Safety and Efficacy Study in Generalized Anxiety Disorder

A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Generalized Anxiety Disorder

Last checked: Nov 19, 2026Latest source record: Sep 24, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingRandomized with 160 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

160

Planned (sponsor's estimate)

Start

Apr 20, 2026

Primary completion

Jul 2027

Study completion Sep 2027

Sponsor

Lead sponsor
Reunion Neuroscience IncIndustry
Sponsor type
Industry
First posted
Mar 24, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 74 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine if treatment with a single and/or repeat dose of RE104 for Injection reduces anxiety symptoms in participants with Generalized Anxiety Disorder (GAD) as compared to placebo.

Conditions

  • Generalized Anxiety Disorder

Interventions

  • RE104 for InjectionDrug

    Single dose (Part A) or Repeat-dose (Part B), subcutaneous injection(s) of RE104 for Injection

  • PlaceboDrug

    Single-dose (Part A) or Repeat-dose (Part B), subcutaneous injection(s) of 0.9% sodium chloride for injection

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. RE104 when administered as a single 30 mg dose or as two 30 mg doses 3 weeks apart versus placebo change from Baseline at Week 4 in Hamilton Anxiety Rating Scale (HAM-A) total scoreTime frame: Week 4

Locations

28 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama (UAB) Clinical Research Unit (CRU)

    Birmingham, Alabama · Recruiting

  • Lighthouse Psychiatry

    Gilbert, Arizona · Recruiting

  • Preferred Research Partners, Inc.

    Little Rock, Arkansas · Recruiting

  • Collaborative Neuroscience Research, LLC

    Garden Grove, California · Recruiting

  • Kadima Neuropsychiatry Institute

    La Jolla, California · Recruiting

  • Open Mind Therapeutics

    San Francisco, California · Recruiting

  • TRIP Clinic at Psychedelic Science Institute

    Santa Monica, California · Recruiting

  • Innovative Clinical Research, Inc.

    Lauderhill, Florida · Recruiting

  • University of South Florida

    Tampa, Florida · Recruiting

  • Atlanta Center for Medical Research

    Atlanta, Georgia · Recruiting

  • CenExel iResearch, LLC

    Decatur, Georgia · Recruiting

  • Evergreen Clinical Trials

    Norcross, Georgia · Recruiting

  • CenExel iResearch, LLC

    Savannah, Georgia · Recruiting

  • Uptown Research Institute

    Chicago, Illinois · Recruiting

  • Henry Ford Medical Center - Columbus

    Novi, Michigan · Recruiting

  • Midwest Research Group

    Saint Charles, Missouri · Recruiting

  • UNM Research Program Psychedelic Therapies

    Albuquerque, New Mexico · Recruiting

  • NYU-H+C Clinical and Translational Science Institute

    New York, New York · Recruiting

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina · Recruiting

  • Neuro-Behavioral Clinical Research, Inc.

    North Canton, Ohio · Recruiting

  • Summit Headlands LLC

    Portland, Oregon · Recruiting

  • University of Pennsylvania

    Philadelphia, Pennsylvania · Recruiting

  • Suburban Research Associates

    West Chester, Pennsylvania · Withdrawn

  • Austin Clinical Trial Partners

    Austin, Texas · Recruiting

  • BioBehavioral Research Austion

    Austin, Texas · Recruiting

  • Aim Trials, LLC

    Plano, Texas · Recruiting

  • Cedar Clinical Research

    Draper, Utah · Recruiting

  • Inner Space State Street

    Orem, Utah · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.